The Case for Embracing the FDA’s Endorsed Data Standards

Provided By:


March 6, 2017

In this white paper, we’ll discuss the guidances compelling organizations to compile data into standardized, digital datasets, the FDA’s motivation behind these changes and the benefits to — as well as the hopes of — the organizations that must submit standardized data.

There is also a related podcast on this topic, which you can listen to using the below link.

Post a Comment

You must be logged in to post a Comment.